A recent study reported that sildenafil, sold under the brand name Viagra, and other medicines from the same group called phosphodiesterase type-5 inhibitors may reduce the risk of Alzheimer's disease. But other research ...
Feb 21, 2024
0
1
For patients with dementia with Lewy bodies (DLB), treatment with acetylcholinesterase inhibitors (AChEIs) and/or memantine is associated with reduced hospital admissions and mortality, according to a study published online ...
Dec 14, 2022
0
48
Clinicians at the Department of Neurology of MedUni Vienna/Vienna General Hospital identified muscle weakness and severe fatigue in a previously healthy patient, to the extent that he was soon confined to a wheelchair. These ...
May 8, 2019
0
0
The prevalence of using antidepressants and proton pump inhibitors increases after the diagnosis of Alzheimer's disease, according to a doctoral dissertation from the University of Eastern Finland. The use of antidepressants ...
Mar 26, 2019
0
5
A study by the UPV/EHU has assessed whether drugs used to delay cognitive deterioration in patients with Alzheimer's are effective in improving cognitive impairments in patients with schizophrenia. Through an analysis of ...
Jan 16, 2019
0
0
Up to half of people with Alzheimer's disease (AD) use a psychotropic drug, and one in five uses two or more psychotropics concomitantly, according to a study conducted at the University of Eastern Finland.
Oct 1, 2018
0
5
(HealthDay)—Discontinuation of acetylcholinesterase inhibitors (AChEIs) for treatment of Alzheimer's disease is common, with adverse effects and cost cited as major factors, according to a study published recently in the ...
Apr 26, 2017
0
0
Memory loss and other cognitive symptoms of Alzheimer's disease are attributed, in part, to the degeneration of acetylcholine-producing neurons. Acetylcholinesterase inhibitors are a common treatment for patients with Alzheimer's; ...
Dec 19, 2016
0
1
A recent study from the University of Eastern Finland shows that among users of antidementia drugs, persons using memantine have the highest risk of pneumonia. The use of rivastigmine patches is associated with an increased ...
Nov 21, 2016
0
2
Despite several safe drug therapies available to help smokers quit, three-quarters report relapsing within six months of a quit attempt. University of Pennsylvania researchers Rebecca Ashare and Heath Schmidt saw potential ...
Feb 18, 2016
0
51
